VALN News

Eight IPOs and four SPACs went public this past week. One IPO postponed, UK-based biotech Gyroscope Therapeutics (VISN), citing market conditions. Filing activity maintained a comfortable pace/remained moderate, with seven IPOs and 10 SPACs submitting initial filings. The week’s best performer, Sacramento bank Five Star Bancorp (FSBC)...read more

Valneva, a commercial-stage French biotech developing vaccines for infectious diseases, raised $94 million by offering 3.5 million ADS equivalents at $26.41, within the range of $24.04 to $28.85. The company originally planned to offer the securities at the as-converted last close of its shares on the Euronext Paris (VLA; $30.35 on 5/5) before setting a price range on Wednesday...read more

Valneva, a commercial-stage French biotech developing vaccines for infectious diseases, revised the terms for its upcoming IPO on Wednesday. The Saint-Herblain, France-based company now plans to raise $94 million by offering 3.5 million ADS equivalents at a price range of $24.04 to $28.85. The company had previously filed to offer the same number of ADS equivalents at $28.24,...read more

Updated Monday, 5/3. 10 IPOs are expected to raise a total of $1.4 billion in the first week of May. The lineup is led by Jessica Alba’s highly-anticipated lifestyle brand, The Honest Company (HNST). The largest deal of the week, non-toxic lifestyle brand The Honest Company (HNST) plans to raise $400 million at a $1.6...read more